Search results for "anticancer"

showing 10 items of 171 documents

Biotin-Containing Reduced Graphene Oxide-Based Nanosystem as a Multieffect Anticancer Agent: Combining Hyperthermia with Targeted Chemotherapy

2015

Among the relevant properties of graphene derivatives, their ability of acting as an energy-converting device so as to produce heat (i.e., thermoablation and hyperthermia) was more recently taken into account for the treatment of solid tumors. In this pioneering study, for the first time, the in vitro RGO-induced hyperthermia was assessed and combined with the stimuli-sensitive anticancer effect of a biotinylated inulin-doxorubicin conjugate (CJ-PEGBT), hence, getting to a nanosystem endowed with synergic anticancer effects and high specificity. CJ-PEGBT was synthesized by linking pentynoic acid and citraconic acid to inulin. The citraconylamide pendants, used as pH reversible spacer, were …

Polymers and PlasticsBiotinAntineoplastic AgentsBreast NeoplasmsBioengineeringlaw.inventionBiomaterialschemistry.chemical_compoundDrug Delivery SystemslawMaterials ChemistrymedicineHumansMoietyOrganic chemistryDoxorubicinChemistryGrapheneInulinHyperthermia InducedHydrogen-Ion ConcentrationCitraconic acidgraphene drug delivery hypertermia anticancer inulinCombinatorial chemistryDoxorubicinSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBiotinylationDrug deliveryMCF-7 CellsNanoparticlesNanomedicineFemaleGraphiteConjugatemedicine.drugBiomacromolecules
researchProduct

Analysis of mebendazole binding to its target biomolecule by laser flash photolysis

2016

[EN] Mebendazole (MBZ) and related anticancer benzimidazoles act binding the beta-subunit of Tubulin (TU) before dimerization with alpha-TU with subsequent blocking microtubule formation. Laser flash photolysis (LFP) is a new tool to investigate drug-albumin interactions and to determine binding parameters such as affinity constant or population of binding sites. The aim of this study was to evaluate the interactions between the nonfluorescent mebendazole (MBZ) and its target biomolecule TU using this technique. Before analyzing the MBZ@TU complex it was needed to determine the photophysical properties of MBZ triplet excited state ((3)MBZ*) in different media. Hence, 3MBZ* showed a transien…

PopulationBiophysicsBinding constantElectron donor010402 general chemistryPhotochemistry01 natural sciencesAnticancer drugschemistry.chemical_compoundQUIMICA ORGANICAMebendazole triplet excited stateTubulinUltrafast laser spectroscopyRadiology Nuclear Medicine and imagingeducationchemistry.chemical_classificationeducation.field_of_studyRadiationPhotolysisRadiological and Ultrasound Technology010405 organic chemistryPhosphorescenceLasersPhotodissociationTemperatureLaser flash photolysisElectron acceptorBinding constant0104 chemical sciencesMebendazolechemistryExcited stateFlash photolysisThermodynamicsSpectrophotometry UltravioletProtein Binding
researchProduct

Anti-Proliferative Activity of A Hydrophilic Extract of Manna from Fraxinus angustifolia Vahl through Mitochondrial Pathway-Mediated Apoptosis and Ce…

2020

Manna is produced from the spontaneous solidification of the sap of some Fraxinus species, and, owing its content in mannitol, is used in medicine as a mild laxative. Manna is also a rich source of characteristic bio-phenols with reducing, antioxidant and anti-inflammatory properties. This study assesses the activity of a hydrophilic extract of manna (HME) on cellular and molecular events in human colon-rectal cancer cells. HME showed a time- and concentration-dependent anti-proliferative activity, measured by MTT assay, in all the cell lines examined, namely Caco-2, HCT-116 and HT-29. The amounts of HME that caused 50% of cell death after a 24 h treatment were 8.51 &plusmn

Programmed cell deathCell cycle checkpointPharmaceutical ScienceCaspase 3anticancerAnalytical Chemistrylcsh:QD241-441<i>Fraxinus angustifolia</i>03 medical and health sciences0302 clinical medicinelcsh:Organic chemistrySettore BIO/10 - BiochimicaDrug DiscoverymedicineMTT assayPhysical and Theoretical Chemistry030304 developmental biologyFraxinus angustifolia0303 health sciencesChemistryOrganic ChemistryapoptosisSettore CHIM/08 - Chimica FarmaceuticaMolecular biologyChemistry (miscellaneous)Apoptosis030220 oncology & carcinogenesisCancer cellMolecular Medicinecolon cancer cellsMannitolIntracellularmannamedicine.drugMolecules
researchProduct

Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents

2014

This paper describes the design, synthesis, and biological evaluation of peptidomimetic boronates as inhibitors of the 20S proteasome, a validated target in the treatment of multiple myeloma. The synthesized compounds showed a good inhibitory profile against the ChT-L activity of 20S proteasome. Compounds bearing a β-alanine residue at the P2 position were the most active, that is, 3-ethylphenylamino and 4-methoxyphenylamino (R)-1-{3-[4-(substituted)-2-oxopyridin-1(2H)-yl]propanamido}-3-methylbutylboronic acids (3 c and 3 d, respectively), and these derivatives showed inhibition constants (Ki ) of 17 and 20 nM, respectively. In addition, they co-inhibited post glutamyl peptide hydrolase act…

Proteasome Endopeptidase ComplexPeptidomimeticStereochemistryCell Survivalanticancer agents; boronates; bortemib; Docking studies; Peptidomimetics; inhibitor; proteasomesAntineoplastic AgentsSaccharomyces cerevisiaedocking studieBiochemistrySubstrate Specificitychemistry.chemical_compoundCell Line TumorDrug DiscoverymedicineMoietyHumansGeneral Pharmacology Toxicology and PharmaceuticsPharmacologychemistry.chemical_classificationBinding SitesproteasomesBortezomibOrganic ChemistrybortezomibboronateBoronic AcidspeptidomimeticProtein Structure Tertiaryanticancer agentMolecular Docking SimulationinhibitorEnzymechemistryProteasomeBiochemistryDocking (molecular)Molecular MedicinePeptidomimeticsGrowth inhibitionDrug Screening Assays AntitumorProteasome InhibitorsBoronic acidmedicine.drug
researchProduct

Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors

2014

Abstract A new series of pseudopeptide boronate proteasome inhibitors (2–3) was developed, through optimization of our previously described analogs of bortezomib, bearing a bicyclic 1,6-naphthyridin-5(6H)-one scaffold as P3 fragment (1). The biological evaluation on human 20S proteasome displayed a promising inhibition profile, especially for compounds bearing a P2 ethylene fragment, which exhibited Ki values in the nanomolar range for the ChT-L activity (e.g. 2a, Ki = 0.057 μM) and considerable selectivity for proteasome over bovine pancreatic α-chymotrypsin. Docking experiments into the yeast 20S proteasome revealed that the ligands are accommodated predominantly into the ChT-L site and t…

Proteasome Endopeptidase ComplexProtein ConformationStereochemistryPeptidomimeticAntineoplastic AgentsPeptidomimetic boronatePeptidomimetic boronates; Docing studies; Proteasome inhibitorsBortezomibchemistry.chemical_compoundCell Line TumorEndopeptidasesDrug DiscoverymedicineAnimalsHumansProteasome inhibitoranticancer drugTrypsinThreonineCell ProliferationPharmacologybiologyBicyclic moleculeBortezomibHydrolysisOrganic ChemistryActive siteGeneral MedicineBoronic AcidsCombinatorial chemistryMolecular Docking SimulationchemistryProteasomeDocking (molecular)Docking studieCaspasesDrug DesignPyrazinesProteolysisbiology.proteinCattlePeptidomimeticsProteasome InhibitorsLead compoundmedicine.drugEuropean Journal of Medicinal Chemistry
researchProduct

An unexpected Dimroth rearrangement leading to annelated thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidines with potent antitumor activity.

2013

An unusual Dimroth rearrangement occurring in the reaction leading to annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidine core allowed the isolation of the linear isomer thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidine. By decorating the linear isomer with the same chains that improved the biological activity of the angular isomers, new annelated thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidines were designed and synthesized. They were selected by the Developmental Therapeutics Program (DTP) of the National Cancer Institute (NCI) for the anticancer screening against a panel of 60 human tumor cell lines. The biological results showed that the new derivatives exhibited strong antiproliferative …

PyrimidineStereochemistryAntineoplastic AgentsAnnelated thienotriazolopyrimidines Domino reactions Dimroth rearrangement Developmental Therapeutics Program (DTP) Anticancer agentsDimroth rearrangementD-1chemistry.chemical_compoundStructure-Activity RelationshipCell Line TumorDrug DiscoveryHumansCell ProliferationPharmacologyAntitumor activityLow toxicityDose-Response Relationship DrugMolecular StructureOrganic ChemistryBiological activityGeneral MedicineTriazolesSettore CHIM/08 - Chimica FarmaceuticaHuman tumorPyrimidineschemistryActive compoundDrug Screening Assays AntitumorEuropean journal of medicinal chemistry
researchProduct

New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol

2012

Drug design was performed through the Virtual Lock-and-Key (VLAK) protocol. This in silico approach allowed to select new annelated thienotriazolopyrimidine derivatives, potentially antitumor drugs. Starting from benzothieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidine and Pyrido[3',2':4,5]thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidine core structures, new derivatives of these nuclei were designed and synthesized. Three of them were selected by the Development Therapeutical Program (DTP) of the National Cancer Institute (NCI) for the anticancer screening against a panel of 60 human tumor cell lines. The biological results showed that the new derivatives exhibited an excellent antiproliferative act…

PyrimidineStereochemistryAntineoplastic AgentsThiophenesStructure-Activity Relationshipchemistry.chemical_compoundCell Line TumorDrug DiscoveryHumansStructure–activity relationshipPotencyAnnelated thienotriazolopyrimidines Domino reactions VLAK protocol Developmental Therapeutics Program (DTP) Anticancer agentsCell ProliferationPharmacologyDose-Response Relationship DrugMolecular StructureLow toxicityOrganic ChemistryGeneral MedicineTriazolesCombinatorial chemistrySettore CHIM/08 - Chimica FarmaceuticaHuman tumorPyrimidineschemistryDrug Screening Assays Antitumor
researchProduct

Protective, antioxidant and antiproliferative activity of grapefruit integropectin on sh-sy5y cells

2021

Tested in vitro on SH-SY5Y neuroblastoma cells, grapefruit IntegroPectin is a powerful protective, antioxidant and antiproliferative agent. The strong antioxidant properties of this new citrus pectin, and its ability to preserve mitochondrial membrane potential and morphology, severely impaired in neurodegenerative disorders, make it an attractive therapeutic and preventive agent for the treatment of oxidative stress-associated brain disorders. Similarly, the ability of this pectic polymer rich in RG-I regions, as well as in naringin, linalool, linalool oxide and limonene adsorbed at the outer surface, to inhibit cell proliferation or even kill, at high doses, neoplastic cells may have open…

SH-SY5YAntioxidantCell SurvivalQH301-705.5medicine.medical_treatmentMitochondrionPharmacologymedicine.disease_causeanticancerNeuroprotectionSettore BIO/09 - FisiologiaAntioxidantsArticleCatalysisInorganic ChemistryNeuroblastomachemistry.chemical_compoundX-Ray DiffractionCell Line Tumorhydrodynamic cavitationmedicineHumansoxidative stressPhysical and Theoretical ChemistryBiology (General)neurological diseaseMolecular BiologyNaringinQD1-999SpectroscopyCell ProliferationantitumorMembrane Potential MitochondrialpectinCell growthChemistryOrganic ChemistryneurodegenerationGeneral MedicinephytochemicalsIn vitroComputer Science ApplicationsmitochondriaChemistryNeuroprotective AgentsPectinscell cycleOxidative stressCitrus paradisi
researchProduct

Enhanced Accumulation of Betulinic Acid in Transgenic Hairy Roots of Senna obtusifolia Growing in the Sprinkle Bioreactor and Evaluation of Their Bio…

2021

Betulinic acid, which is found in transgenic roots of Senna obtusifolia (L.) H.S.Irwin & Barneby, is a pentacyclic triterpene with distinctive pharmacological activities. In this study, we report the differences in the content of betulinic acid and selected anthraquinones in transgenic S. obtusifolia hairy roots with overexpression of the PgSS1 gene (SOPSS2 line) and in transformed hairy roots without this genetic construct (SOA41 line). Both hairy root lines grew in 10 L sprinkle bioreactor. Additionally, the extracts obtained from this plant material were used for biological tests. Our results demonstrated that the SOPSS2 hairy root cultures from the bioreactor showed an increase in the c…

Senna PlantTransgeneBioengineeringAnthraquinonesApoptosisMicrobial Sensitivity TestsGram-Positive BacteriaBiochemistryModels BiologicalPlant Rootschemistry.chemical_compoundBioreactorsTriterpeneGene Expression Regulation PlantBetulinic acidCell Line TumorAnthraquinonesGene expressionGram-Negative BacteriaBioreactorHumansAntiviral activityBetulinic AcidMolecular BiologyCell ProliferationPlant Proteinsbcl-2-Associated X Proteinchemistry.chemical_classificationbiologyPlant ExtractsSprinkle bioreactorGeneral ChemistryGeneral Medicinebiology.organism_classificationAntimicrobialPlants Genetically ModifiedBiodiversitatAnticancerchemistryBiochemistryGlucosyltransferasesTransgenic hairy rootsMolecular MedicineAntimicrobialGene expressionTumor Suppressor Protein p53Senna obtusifoliaPentacyclic TriterpenesChemistrybiodiversity
researchProduct

Effetti antiproliferativi degli estratti di emociti dell'ascidia Styela plicata ( Tunicata)

2009

Settore BIO/13 - Biologia Applicatatunicates Styela marine natural products anticancer activity
researchProduct